| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3293320 | Gastroenterology | 2012 | 9 Pages |
Abstract
G-CSF therapy more than doubles the percentage of patients with ACLF who survive for 2 months; it also significantly reduces CTP, MELD, and SOFA scores and prevents the development of sepsis, hepatorenal syndrome, and hepatic encephalopathy.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Vishal Garg, Hitendra Garg, Arshi Khan, Nirupama Trehanpati, Ashish Kumar, Barjesh Chander Sharma, Puja Sakhuja, Shiv Kumar Sarin,